Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.

Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision identifier, upgraded from v3.6.5 to v3.6.6, indicating an updated version of the page in the ClinicalTrials.gov record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision label, Revision: v3.6.5, has been added to replace the previous v3.6.4. This indicates an updated version reference in the page's records without changing substantive content.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page shows an updated site revision label to v3.6.4, indicating a new release of the interface. No substantive changes to the study details or eligibility information are evident in the provided data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision metadata was updated to v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new version of the page metadata. This change represents an updated page revision rather than a substantive update to study content.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status now indicates no longer looking for participants, new help sections were added, and the Interventions heading formatting was updated (Intervention/Treatment added; Intervention / Treatment removed) alongside a version label change.SummaryDifference0.5%

Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.